Avantor Inc
Avantor Inc (NYSE: AVTR) is a global supplier of products, services and consumables to the life sciences, healthcare and advanced technologies markets. The company offers laboratory chemicals, ultrapurified water solutions, bioprocessing supplies and distribution services used by pharmaceutical, biotech, academic and industrial customers. With a market capitalisation of around $10.64 billion, Avantor’s business is driven by recurring demand for lab consumables, growth in biologics and diagnostics, and expansion into international markets. Investors often watch revenue diversity across healthcare and industrial end-markets, margins on speciality products, and cash generation. Key risks include exposure to raw-material and logistics costs, customer concentration, regulatory changes and competitive pressure. Avantor may pursue acquisitions to bolster its portfolio, which can affect leverage and integration risk. This summary is for educational purposes only and not personalised investment advice; values can rise and fall and past performance does not guarantee future returns. Consider suitability and seek independent advice if unsure.
Stock Performance Snapshot
Analyst Rating
Analysts suggest holding Avantor's stock, with a target price indicating potential for slight growth.
Financial Health
Avantor is performing well with strong revenue and cash flow, indicating solid business operations.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring AVTR
Pharma Onshoring Boom: Investment Risk Considerations
AstraZeneca is building a major new manufacturing plant in the U.S., responding to policy pressures for domestic production. This signals a broader trend of onshoring pharmaceutical manufacturing, creating opportunities for companies that build and equip these advanced facilities.
Published: October 10, 2025
Explore BasketPharma's American Reshoring Wave
AstraZeneca is investing $50 billion to expand its U.S. manufacturing, partly in response to trade tariffs. This move could spark a wave of similar onshoring efforts, creating opportunities for companies that build, equip, and supply the growing domestic biopharmaceutical industry.
Published: July 23, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Steady Consumables Demand
Recurring purchases of lab reagents and disposables can provide reliable revenue, though end-market cycles and budget shifts may affect volumes.
Global Footprint
Broad geographic reach helps diversify customers across pharma, academia and industry, but exposes the business to currency and regional regulatory risks.
Operational Levers
Efficiency, pricing on speciality products and integration of acquisitions can lift margins, though execution and cost pressures are ongoing considerations.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Abbott Laboratories
Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.
Agilent Technologies Inc.
Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. Life Sciences and Diagnostics Markets segment comprises seven areas of activity. It offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. Agilent CrossLab segment offers a services and consumables portfolio that spans the entire lab, in addition to software and laboratory automation solutions, which are designed to enhance customer outcomes. Applied Markets segment offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products.
Align Technology Inc.
Align Technology is a medical device company that designs, manufactures and markets a range of dental and orthodontic products.
